https://seekingalpha.com/news/4065708-csl-limited-stock-falls-after-phase-3-setback?source=feed_sector_healthcare
Feb 12, 2024 - Australian biotech CSL Limited (CSLLY) experienced a 4% intraday loss after its Phase 3 AEGIS-II trial, aimed at reducing cardiovascular events, failed.
0
sa:1496509908254401699
0
https://seekingalpha.com/article/4669675-csl-ltd-cslly-q2-2024-earnings-call-transcript?source=feed_all_articles
Feb 12, 2024 - CSL Ltd (OTCQX:CSLLY) Q2 2024 Earnings Conference Call February 12, 2024 7:00 PM ETCompany ParticipantsMark Dehring - Head, IRPaul McKenzie - MD, CEO &...
0
sa:-4636134803218624745
0
https://www.zacks.com/stock/news/2203224/4-garp-stocks-to-scoop-up-for-maximum-returns?cid=CS-ZC-FT-analyst_blog|rw-2203224
Dec 28, 2023 - Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. ARCO, NVDA, NRG and CSL are some stocks that hold promise.
zc:-2053181684820853818
0
https://www.zacks.com/stock/news/2205784/itt-gains-more-than-38-in-a-year-will-the-growth-continue?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2205784
Jan 04, 2024 - Strength in the aftermarket business within the Industrial Process segment bodes well for ITT. The company's measures to reward its shareholders are impressive.
zc:2718972887067984195
0
https://www.zacks.com/stock/news/2220202/insights-into-carlisle-csl-q4-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220202
Feb 02, 2024 - Besides Wall Street's top -and-bottom-line estimates for Carlisle (CSL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
zc:8085108612888552339
0
https://www.zacks.com/stock/news/2220462/will-carlisle-csl-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2220462
Feb 02, 2024 - Carlisle (CSL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:1723798158331260646
0
https://www.zacks.com/stock/news/2222152/carlisle-csl-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2222152
Feb 06, 2024 - Carlisle (CSL) delivered earnings and revenue surprises of 20.17% and 3.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:273109589102151336
0
https://www.zacks.com/stock/news/2228924/3-stocks-to-buy-out-of-the-top-rated-zacks-diversified-operations-industry?cid=CS-ZC-FT-video_blog-2228924
Feb 20, 2024 - The growth prospects of these Zacks Diversified Operations Industry stocks are very intriguing considering their reasonable valuations.
zc:-7852844338444116250
0
https://www.zacks.com/stock/news/2232484/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2232484
Feb 27, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:2949653874909805734
0
https://www.zacks.com/stock/news/2241573/itt-gains-from-end-market-strength-buyouts-amid-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2241573
Mar 15, 2024 - ITT gains from strength in energy, mining and decarbonization markets, Svanehoj buyout and shareholder-friendly policies. However, softness in the global auto market is concerning.
zc:-5380738715009719336
0